The World Health Organization validated Algeria’s elimination of trachoma as a public health problem, making it the 10th country in the WHO African Region and the 29th globally to reach this milestone. 

São Tomé and Príncipe is nearing elimination of lymphatic filariasis as a public health problem, following rapid adoption of WHO-recommended triple drug therapy (IDA) and consistently high treatment coverage. Post-MDA surveys show extremely low infection levels and no evidence of ongoing transmission, positioning the country as a strong example of accelerated progress through effective leadership, partnership, and data-driven strategies.

The ESPEN Collect platform has reached a new milestone with the launch of its Mass Drug Administration (MDA) module, expanding its scope from mapping and surveys to real-time monitoring of treatment campaigns. This integrated digital tool enables countries to track medicine distribution, supervision, and coverage more efficiently, strengthening data-driven decision-making in the fight against NTDs.

ESPEN and Sightsavers co-hosted a regional webinar in March 2026 to share lessons learned in lymphatic filariasis (LF) dossier development and strengthen country readiness for validation. The session highlighted the importance of early, continuous documentation and alignment with WHO guidance to support a smooth validation process. Key insights and practical recommendations are now available to guide countries progressing toward elimination of LF as a public health problem.